Drug Development Consulting BidCo ApS

Past relations

Ultimate beneficial owners (UBOs): Alejandra Maria Cristina Bonifacini Mørk
2021-05-17 – 2022-12-22 26.32% ownership (2021-05-17 – 2022-12-22 ) 25.37% voting rights (2021-05-17 – 2022-12-22 )
Legal owners: Drug Development Consulting Holding ApS 100% ownership (2021-04-08 – ) 100% voting rights (2021-04-08 – )
Directors: René Holmen Pedersen
2023-06-01 –

Rasmus Koch Nelund
2023-05-01 – 2025-02-28

Alejandra Maria Cristina Bonifacini Mørk
2021-05-17 – 2023-04-30

Jasper Michiel van Gorp
2021-04-08 – 2021-05-17
Board members: Niels Peder Nielsen
2023-03-16 –

Alejandra Maria Cristina Bonifacini Mørk
2023-03-16 –

Rafael Natanek
2023-03-16 –

Redmar Koene
2021-05-17 –

Mette Kirstine Agger
2021-05-17 – 2024-04-25

Rafael Natanek
2021-05-17 – 2023-03-15

Drug Development Consulting BidCo ApS has 2.00 full time equivalents (FTEs) and 2.00 employees as of 1 May, 2025.